Clinical Trial Update: Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome

View source ↗

Summary

A completed clinical trial comparing buffered and enteric-coated aspirin and their effects on platelet aggregation in patients with type 2 diabetes and chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (buffered) (aspirin)
• Aspirin (enteric-coated) (acetylsalicylic acid)

Snippet

Sponsor: Nizhpharm | Conditions: Diabetes Mellitus Type 2, Coronary Artery Diseases | Status: COMPLETED